CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 1,956 shares at $18.91 ($36,988)
- 4 Open-market sale Chief Financial Officer sold 2,157 shares at $18.91 ($40,789)
- 4 Open-market sale Chief Business Officer sold 1,718 shares at $18.91 ($32,487)
- 4 Open-market sale Chief Scientific Officer sold 1,576 shares at $18.91 ($29,802)
- 4 Open-market sale CMO sold 3,682 shares at $18.91 ($69,627)
- 4 Open-market sale President and CEO sold 3,152 shares at $18.91 ($59,604)
- 4 Planned sale General Counsel sold 29,835 shares at an average $20.00 ($596,805)
- 4 Planned sale Chief Business Officer sold 10,000 shares at an average $20.03 ($200,258)
Page 5 of 11 · 203 filings